Target intelligence / Profile preview

Nasal mucous membrane receptor

Molecular classification
G protein-coupled receptor, Nuclear receptor, Ion channel, Receptor
01

Overview

Nasal mucous membrane receptors is a collective term referring to a heterogeneous group of receptor proteins located within the respiratory and olfactory epithelia of the nasal cavity. This group includes alpha-adrenergic receptors (alpha-1 and alpha-2) that regulate vascular tone and mucosal thickness, and histamine H1 receptors that mediate allergic responses like sneezing and itching (StatPearls: Oxymetazoline, 2023). The mucosa also contains glucocorticoid receptors, which are targeted by intranasal steroids to manage chronic inflammation in allergic rhinitis and nasal polyposis, and muscarinic receptors that control mucus production by seromucous glands. Furthermore, the specialized olfactory epithelium houses a large family of olfactory receptors (G protein-coupled receptors) responsible for the detection of odorants and the sense of smell (Nature: Olfactory Receptors, 2014). Because this designation refers to an anatomical collection of various molecular targets rather than a single specific protein, it is considered a broad functional classification rather than a distinct therapeutic target in molecular biology. Local delivery of drugs to these receptors allows for high therapeutic concentrations at the site of disease with minimal systemic side effects.

Other names
Nasal receptorsReceptors of the nasal mucosaIntranasal drug targetsNasal mucosa receptors
02

Mechanism of action

Agonism of alpha-1 and alpha-2 adrenergic receptors induces vasoconstriction of nasal mucosal blood vessels to reduce swelling; antagonism of Histamine H1 receptors inhibits allergic inflammation and symptoms; activation of glucocorticoid receptors provides broad anti-inflammatory effects; antagonism of muscarinic receptors reduces glandular secretions (rhinorrhea).

03

Biological functions

VasoconstrictionInflammatory responseSensory perception (olfaction)Mucus secretionChemoreception
04

Disease associations

Allergic rhinitisNasal congestionSinusitisAnosmiaVasomotor rhinitis
05

Safety considerations

Rhinitis medicamentosa (rebound congestion from alpha-agonist overuse)Nasal septal perforationEpistaxis (nosebleeds)Mucosal atrophyLocal irritation or burning sensation
06

Interacting drugs

Oxymetazoline

6 more in the full profile.

07

Biomarkers

Total Nasal Symptom Score (TNSS)Nasal Peak Inspiratory Flow (NPIF)Acoustic rhinometry (nasal volume)Nasal eosinophilia

Beyond the preview

Go deeper on Nasal mucous membrane receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nasal mucous membrane receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call